The ‘MYCN’ gene creates a specific nook that turns healthy liver cells into cancer. Detecting MYCN gene early could help identify and reduce liver cancer risk.

Khaberni - Early cancer detection technologies are undergoing a radical transformation with the emergence of multicancer blood tests (MCED), which rely on the analysis of free DNA ...

Grail continues facing significant challenges as its stock plummeted over 45% after its landmark NHS-Galleri trial failed to ...

The Primary Endpoint of Statistically Significant Combined Stage III-IV Reduction Was Not Met, However A Favorable Trend Was Observed Over Time GRAIL Announces U.S. Sales Force Expansion Based on ...

A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across ...

Devices shown at AI Impact Summit can be deployed across hospitals and resource-scarce settings to improve accuracy and accessibility.

A powerful artificial intelligence (AI) tool could give clinicians a head start in identifying life-threatening complications ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue financial results for the fourth quarter and full year ...

GRAIL reported that 2025 total revenue rose 17% year on year to $147.2 million, driven by a 26% increase in U.S. Galleri sales to $136.8 million, while net loss narrowed sharply to $408.4 million and ...

Insulin resistance - when the body doesn't properly respond to insulin, a hormone that helps control blood glucose levels - is one of the fundamental causes of diabetes. In addition to diabetes, it is ...

CCNSB researchers at IIIT Hyderabad focus on genomics, epigenetics and AI for cancer detection and treatment: Our Bureau, Bengaluru Monday, February 16, 2026, 15:50 Hrs [IST] Rese ...

The researchers published their findings in the journal Nature Communications.